Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
暂无分享,去创建一个
L. Pagano | F. Farina | E. D. de Kort | A. Tragiannidis | A. Busca | A. Antoniadou | N. Khanna | J. Maertens | J. Meletiadis | P. Žák | N. Fracchiolla | E. Gavriilaki | J. Salmanton-García | M. Nucci | G. Seval | O. Ilhan | P. Tsirigotis | V. Petzer | J. V. Van Praet | Z. Ráčil | I. Falces-Romero | A. Tanase | F. Marchesi | R. Duarte | A. Kulasekararaj | I. Espigado | A. López-García | E. Ammatuna | M. Marchetti | M. Machado | L. Prezioso | N. Bahr | A. Glenthøj | L. Karlsson | L. Verga | B. Weinbergerová | O. Blennow | A. Nordlander | G. Dragonetti | S. Gräfe | M. Schönlein | M. Hanáková | F. Itri | J. V. van Doesum | M. Jiménez | A. Cabirta | M. Dargenio | G. Magliano | G. Zambrotta | Caroline Berg Venemyr | Sofia Zompi | A. Groh | N. D. de Jonge | L. Rahimli | O. Cornely | José-María Ribera-Santa Susana
[1] L. Pagano,et al. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA) , 2022, Frontiers in Oncology.
[2] N. Ledeboer,et al. Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients , 2022, Cancer Cell.
[3] P. Chevallier,et al. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients , 2021, Blood.
[4] A. Barać,et al. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) , 2021, Journal of Hematology & Oncology.
[5] R. Balusu,et al. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients , 2021, Transplantation and Cellular Therapy.
[6] L. Pagano,et al. EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19 , 2021, HemaSphere.
[7] N. Kröger,et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey , 2021, Leukemia.
[8] L. Lekakis,et al. Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy , 2021, Transplant infectious disease : an official journal of the Transplantation Society.
[9] M. Perales,et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study , 2021, The Lancet Haematology.
[10] S. Başcı,et al. COVID-19 in hematopoietic cell transplant recipients , 2020, Bone Marrow Transplantation.
[11] F. Moreso,et al. COVID-19 in transplant recipients: The Spanish experience , 2020, American Journal of Transplantation.
[12] N. E. Babady,et al. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation. , 2020, The Journal of clinical investigation.
[13] C. Solano,et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies , 2020, Experimental Hematology & Oncology.
[14] J. Mehta,et al. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter , 2020, Leukemia.
[15] G. Corrao,et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study , 2020, The Lancet Haematology.
[16] M. Graham,et al. Severity of cytokine release syndrome and its association with infections after T-cell replete haploidentical related donor transplantation. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] S. Revannasiddaiah,et al. A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2 , 2020, Medical Hypotheses.
[18] M. B. Abid,et al. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment. , 2020, JAMA oncology.
[19] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[20] Hui Li,et al. A Novel Coronavirus (COVID-19) Outbreak , 2020, Chest.
[21] S. Perlman,et al. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.
[22] L. Luznik,et al. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. , 2012, Seminars in oncology.
[23] J. Routy,et al. Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation , 2019, Medicine.
[24] Thomas,et al. The Spanish experience , 2004 .
[25] D. Hay,et al. Call for action. , 1971, Nursing mirror and midwives journal.